» Articles » PMID: 36845658

The Impact of Iron Deposition on the Fear Circuit of the Brain in Patients with Parkinson's Disease and Anxiety

Overview
Specialty Geriatrics
Date 2023 Feb 27
PMID 36845658
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Anxiety is one of the most common psychiatric symptoms of Parkinson's disease (PD), and brain iron deposition is considered to be one of the pathological mechanisms of PD. The objective of this study was to explore alterations in brain iron deposition in PD patients with anxiety compared to PD patients without anxiety, especially in the fear circuit.

Methods: Sixteen PD patients with anxiety, 23 PD patients without anxiety, and 26 healthy elderly controls were enrolled prospectively. All subjects underwent neuropsychological assessments and brain magnetic resonance imaging (MRI) examinations. Voxel-based morphometry (VBM) was used to study morphological brain differences between the groups. Quantitative susceptibility mapping (QSM), an MRI technique capable of quantifying susceptibility changes in brain tissue, was used to compare susceptibility changes in the whole brain among the three groups. The correlations between brain susceptibility changes and anxiety scores quantified using the Hamilton Anxiety Rating Scale (HAMA) were compared and analyzed.

Results: PD patients with anxiety had a longer duration of PD and higher HAMA scores than PD patients without anxiety. No morphological brain differences were observed between the groups. In contrast, voxel-based and ROI-based QSM analyses showed that PD patients with anxiety had significantly increased QSM values in the medial prefrontal cortex, anterior cingulate cortex, hippocampus, precuneus, and angular cortex. Furthermore, the QSM values of some of these brain regions were positively correlated with the HAMA scores (medial prefrontal cortex:  = 0.255,  = 0.04; anterior cingulate cortex:  = 0.381,  < 0.01; hippocampus:  = 0.496,  < 0.01).

Conclusion: Our findings support the idea that anxiety in PD is associated with iron burden in the brain fear circuit, providing a possible new approach to explaining the potential neural mechanism of anxiety in PD.

Citing Articles

Homeostasis and metabolism of iron and other metal ions in neurodegenerative diseases.

Chen L, Shen Q, Liu Y, Zhang Y, Sun L, Ma X Signal Transduct Target Ther. 2025; 10(1):31.

PMID: 39894843 PMC: 11788444. DOI: 10.1038/s41392-024-02071-0.


Causal associations between iron levels in subcortical brain regions and psychiatric disorders: a Mendelian randomization study.

Du W, Tang B, Liu S, Zhang W, Lui S Transl Psychiatry. 2025; 15(1):19.

PMID: 39843424 PMC: 11754438. DOI: 10.1038/s41398-025-03231-8.


Association between deep gray matter iron deposition and clinical symptoms in Parkinson's disease: a quantitative susceptibility mapping study.

Zhao H, Ji Q, Jia Z, Shen L Front Neurol. 2025; 15():1442903.

PMID: 39835146 PMC: 11743366. DOI: 10.3389/fneur.2024.1442903.


Integrated network pharmacology and transcriptomics to explore the mechanism of compound Dihuang granule (CDG) protects dopaminergic neurons by regulating the Nrf2/HMOX1 pathway in the 6-OHDA/MPP-induced model of Parkinson's disease.

Sun X, Yang S, He Z, Wang L, He J Chin Med. 2024; 19(1):170.

PMID: 39696456 PMC: 11654441. DOI: 10.1186/s13020-024-01040-7.


Quantitative susceptibility mapping of the fear circuit: Associations with silent symptoms in relapsing-remitting multiple sclerosis.

Khormi I, Fazlollahi A, Al-Iedani O, Vidyasagar R, Ayton S, Alshehri A Neuroradiol J. 2024; :19714009241303123.

PMID: 39631056 PMC: 11618841. DOI: 10.1177/19714009241303123.


References
1.
Chen J, Cai T, Li Y, Chi J, Rong S, He C . Different iron deposition patterns in Parkinson's disease subtypes: a quantitative susceptibility mapping study. Quant Imaging Med Surg. 2020; 10(11):2168-2176. PMC: 7547259. DOI: 10.21037/qims-20-285. View

2.
Beard J, Erikson K, Jones B . Neurobehavioral analysis of developmental iron deficiency in rats. Behav Brain Res. 2002; 134(1-2):517-24. DOI: 10.1016/s0166-4328(02)00092-x. View

3.
Mah L, Szabuniewicz C, Fiocco A . Can anxiety damage the brain?. Curr Opin Psychiatry. 2015; 29(1):56-63. DOI: 10.1097/YCO.0000000000000223. View

4.
Bayram E, Kaplan N, Shan G, Caldwell J . The longitudinal associations between cognition, mood and striatal dopaminergic binding in Parkinson's Disease. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2019; 27(4):581-594. PMC: 8763139. DOI: 10.1080/13825585.2019.1653445. View

5.
Bannerman D, Sprengel R, Sanderson D, McHugh S, Rawlins J, Monyer H . Hippocampal synaptic plasticity, spatial memory and anxiety. Nat Rev Neurosci. 2014; 15(3):181-92. DOI: 10.1038/nrn3677. View